A. Kim

Upgraded Methodology for the Development of Early Diagnosis of Parkinson’s Disease Based on Searching Blood Markers in Patients and Experimental Models

S. Georgieva, N. Soshnikova, N. Vorobyeva, 2018, Molecular Neurobiology.

Development of early diagnosis of Parkinson's disease on animal models based on the intranasal administration of α-methyl-p-tyrosine methyl ester in a gel system.

M. Gorshkova, E. Pavlova, V. Bogdanov, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[Endothelins and dopamine levels in tears for assessment of neurovascular disorders in glaucoma].

N. G. Davydova, N. Chesnokova, T. Pavlenko, 2018, Vestnik oftalmologii.

A Pilot Study of Changes in the Level of Catecholamines and the Activity of α-2-Macroglobulin in the Tear Fluid of Patients with Parkinson’s Disease and Parkinsonian Mice

N. Chesnokova, T. Pavlenko, E. Pavlova, 2021, International journal of molecular sciences.

Tear Fluid Catecholamines As Biomarkers of the Parkinson’s Disease: A Clinical and Experimental Study

N. Chesnokova, T. Pavlenko, M. Ugrumov, 2019, Acta naturae.

Molecular Mechanisms and Clinical Manifestations of Catecholamine Dysfunction in the Eye in Parkinson’s Disease As a Basis for Developing Early Diagnosis

N. Chesnokova, T. Pavlenko, M. Ugrumov, 2020, Acta naturae.

Upgraded Methodology for the Development of Early Diagnosis of Parkinson’s Disease Based on Searching Blood Markers in Patients and Experimental Models

S. Georgieva, N. Soshnikova, N. Vorobyeva, 2018, Molecular Neurobiology.